Evaluation of Novel N‐(piperidine‐4‐yl)benzamide Derivatives as Potential Cell Cycle Inhibitors in HepG2 Cells
Publisher: John Wiley & Sons Inc
E-ISSN: 1747-0285|86|2|223-231
ISSN: 1747-0277
Source: CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol.86, Iss.2, 2015-08, pp. : 223-231
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract